US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

  • Biopharmaceuticals (265)
  • Diseases & Conditions (4081)
  • Drug Delivery (287)
  • Therapeutic Area (7349)
  • Vaccines (725)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

5  6  7  8    10    12  13  14  
Adult Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014
8/30/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Adult Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014
8/30/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Respiratory Distress Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
USD 2,500
GlaxoSmithKline plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' GlaxoSmithKline plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Digestive Remedies - Germany
9/4/2014 | published by: Euromonitor International
... growth in digestive remedies varied greatly, with digestive enzymes declining by 1% in current value terms while proton pump inhibitors recorded double-digit value growth of 23%. Euromonitor International's Digestive Remedies in Germany report offers a ...  |  read more...
USD 900
Medicago, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Medicago, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Oculus Innovative Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oculus Innovative Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, ...  |  read more...
USD 350
Biotie Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Biotie Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Herbal/Traditional Products - Germany
9/4/2014 | published by: Euromonitor International
... of 2% and herbal/traditional digestive remedies posting a decline of 3%. Herbal/traditional cough, cold and allergy (hay fever) remedies recorded a decline of 1%. As the biggest category, it was largely responsible for the sluggish ...  |  read more...
USD 900
Consumer Health - Japan
9/4/2014 | published by: Euromonitor International
... rose and the effects of Abenomics took shape across the country. In particular, OTC and dietary supplements posted positive growth for the year, however, categories such as vitamins and weight management continued to perform poorly ...  |  read more...
USD 2,400
Apotex, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Apotex, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Depomed, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Depomed, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023
8/25/2014 | published by: GlobalData
... the very small tubes in the kidney that transport waste molecules from the blood to the urine. The condition is asymptomatic in its initial stages, and as a result, people with RCC are often in ...  |  read more...
USD 3,995
Bahrain Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... to only moderategrowth in the short term. Longer term, the country's ageing population, increasing chronic diseases burdenand robust economic growth will drive medicine demand; however, further medicine price cuts, lower-thanexpectedoil prices in coming years and ...  |  read more...
USD 1,295
Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cardium Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Belgium Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... per capita spending onpharmaceuticals is relatively high, it is subjected to continual downward pressure from Eastern Europe andAsia, which translates into growth opportunities for generic drugs. However, prescribers' brand loyalty,pay-to-delay deals, the near-universal unpopularity of ...  |  read more...
USD 1,295
BioWa, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
8/29/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' BioWa, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Germany Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... putting furtherpressure on drugmakers looking to benefit from marketing their products in other European markets. Despite this situation, Germany will remain an attractive market to drugmakers. The long-term and clearnature of the price measures implemented ...  |  read more...
USD 1,295
Hungary Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... risk team also sees potential headwindsto spending growth, namely Hungary's excessive government deficits. Under Deficit Procedure rules,Hungary will be forced to trim back its fiscal spending, with negative implications for healthcare. Pricingpressures and slow uptake ...  |  read more...
USD 1,295
Jordan Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... stillprevalent in the market, although steps are being taken to combat this, such as the Jordan Food and DrugAdministration (JFDA)'s recent conference. Although we forecast growth for both the pharmaceutical andhealthcare sectors, our outlook is ...  |  read more...
USD 1,295
Romania Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... in theconsumer outlook and the country's macroeconomic prospects, in line with the views of our Country Riskteam. Provided unemployment continues to pare down and economic growth continues, the pharmaceuticalmarket will continue on its current growth ...  |  read more...
USD 1,295
EpiCast Report: Asthma - Epidemiology Forecast to 2023
9/10/2014 | published by: GlobalData
... characterized by narrowing of the airways, leading to airflow limitation and airway hyper-responsiveness whenever the lungs come into contact with endogenous and exogenous irritants. Exposure to irritants instigates a series of events, such as swelling ...  |  read more...
USD 3,995
Moderate Psoriasis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Moderate Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Drug Discovery Technologies - A Global Market Overview
8/28/2014 | published by: Industry Experts
... in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has ...  |  read more...
USD 3,060
Cachexia - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... Cachexia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Fatigue - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... Fatigue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
5  6  7  8    10    12  13  14